Because of the imperfect nature of biomedical research, even outstanding scientists may make problematic recommendations for public science policy. Preeminent stem cell biologist Dr. Mahendra Rao is promoting cost-effective strategies for establishing public banks of induced pluripotent stem cells (iPSCs). Dr. Rao presented his iPSC bank concept for drug development applications in a recent lecture at the 2014 World Stem Cell Summit; and in a recent report he recommended strategies for developing banked iPSCs for cell therapies. The main motivation given for these banks is the prospect of using iPSCs in drug development and cell therapy – applications, which even Dr. Rao acknowledges face major biological roadblocks. Because of the now routine quality of iPSC production, Dr. Rao argues that we should invest in public banks that would integrate distributed resources to produce more and better cells in less time. However, he minimizes the inherent mutation and immature development problems of iPSCs, and he does not address their inability to renew human organs and tissues like adult stem cells. Pouring money into iPSCs would certainly not be wasted, but misappropriating what can be achieved with them undermines efforts with adult stem cells, which can actually advance stem cell medicine.
Related Posts
Recent Posts
- Asymmetrex® Gives First Cell Culture Core Facility Introduction to Online Rapid Stem Cell Counting in the Institute for Applied Life Sciences at UMassAmherst
- Asymmetrex’s Introduction of Online Calculators for Determination of the Dosage of Therapeutic Stem Cells Announced as a Reformation in Stem Cell Science and Medicine
- Asymmetrex® Interviewed by Tech Company News About Plans to Introduce Online Rapid-Counting Calculators for Quantifying Therapeutic Tissue Stem Cells
- Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter
- Asymmetrex® Presents New Developments in its Rapid Stem Cell Counting Technology at the ARMI|BioFabUSA Meeting in the Millyard on Regenerative Medicine Biomanufacturing
Tags
- Adult Stem Cells
- Announcements
- Asymmetrex News
- Biotechnology
- Immortality and Stem Cells
- Industry News
- Interview
- Kinetic Stem Cell Counting
- Online Workshop
- Regenerative Medicine
- Reports
- Stem Cell Counting
- Stem Cell Information
- Stem Cell Injections
- Stem Cell Medicine
- Stem Cell Research
- Stem Cell Technology
- Stem Cell Toxicology
- Webinar
Leave a Reply